Retrospective claims analysis of the epidemiology and economic burden of diagnosed congenital cytomegalovirus in Japan
Infants diagnosed with cCMV in Japan had, on average, substantially higher HRU and healthcare cost burden than non-cCMV controls in the first two years of life.
Authors
- Philip O. Buck (ORCID: https://orcid.org/0000-0002-3898-3669)
- John Diaz‐Decaro (ORCID: https://orcid.org/0000-0001-6487-2113)
- Debbie Goldschmidt (ORCID: https://orcid.org/0000-0002-8334-2211)
- Urvi Desai (ORCID: https://orcid.org/0000-0001-5196-7201)
- Noam Y. Kirson (ORCID: https://orcid.org/0000-0001-5200-6883)
- Annika Anderson (ORCID: https://orcid.org/0000-0001-6319-9959)
Institutions
- Moderna Therapeutics (United States) (US)
Publication Details
- Journal
- Current Medical Research and Opinion
- Published
- 2025-08-03
- DOI
- https://doi.org/10.1080/03007995.2025.2554734
- Primary Topic
- Cytomegalovirus and herpesvirus research
- Type
- article
- Field-Weighted Citation Impact
- 0.00